8-K: Hanesbrands sets vote, adds merger valuation data

Hanesbrands scheduled a Nov. 25 shareholder vote on its sale to Gildan and issued detailed supplemental valuation disclosures amid stockholder litigation.

Summary

• Shareholders will vote virtually on November 25, 2025 at 9:00 a.m. ET to approve the merger with Gildan; record date is September 30, 2025.
• Consideration per Hanesbrands share: 0.102 Gildan common shares plus $0.80 in cash, without interest.
• Supplemental valuation disclosures detail Goldman Sachs analyses, including standalone discounted cash flow (DCF) implying $4.99–$8.14 per HBI share.
• Pro forma combined-company DCF implies consideration of $6.34–$9.94 per HBI share; a separate present value of future share price analysis implies $5.87–$8.70.
• Selected transactions analysis using 6.0x–9.3x EV/LTM EBITDA multiples implies $2.58–$7.28 per HBI share.
• Key inputs: terminal unlevered FCF of ~$434 million (HBI standalone) and ~$1.3 billion (pro forma), WACC ranges of 9.75%–11.75% (HBI) and 9.25%–11.25% (pro forma).
• Balance sheet references at June 28/29, 2025: HBI total debt ~$2.4 billion, cash ~$220 million; pro forma total debt ~$4.2 billion, cash ~$306 million; HBI FD shares ~364 million; pro forma FD shares ~190 million.
• Net operating loss (NOL) benefits estimated at ~$155 million through 2026 (implied cash tax savings of $33 million shown).
• Hanesbrands received stockholder litigation (Burke and Carroll complaints) and demand letters alleging disclosure deficiencies; the company denies the allegations and voluntarily added disclosures to moot claims.
• The board unanimously recommends voting FOR the transaction and related proposals.

Sentiment

Score: 6

Explanation: Clear deal timetable and detailed valuation support are positives; however, litigation, financing, regulatory approvals, and integration risks temper the outlook.

Positives

• Clear transaction terms: 0.102 Gildan shares + $0.80 cash per Hanesbrands share.
• Board recommendation remains FOR the merger, with definitive proxy/prospectus effective and mailed on October 23, 2025.
• Pro forma combined DCF consideration range of $6.34–$9.94 per share indicates potential value above parts of standalone ranges.
• Standalone DCF supports a value range of $4.99–$8.14 per share using terminal FCF of ~$434 million and WACC of 9.75%–11.75%.
• NOL benefits of approximately $155 million through 2026 (plus an explicit $33 million cash tax savings line) provide incremental value.
• Supplemental disclosures improve transparency on assumptions (discount rates, growth rates, EBITDA exit multiples, debt, cash and share counts).

Negatives

• Stockholder litigation (Burke and Carroll complaints) seeks injunctions, fees, and potential damages if the deal closes.
• Selected transactions analysis implies a low-end value as low as $2.58 per share, highlighting downside scenarios.
• High leverage referenced: Hanesbrands total debt of approximately $2.4 billion and pro forma combined debt of approximately $4.2 billion.
• Multiple regulatory, financing, integration, and execution risks are flagged in forward-looking statements, including ability to obtain and replace debt financing.

Risks

• Timing and completion risk, including receipt of all required Gildan and Hanesbrands approvals to satisfy closing conditions.
• Realization, timing, and magnitude of anticipated synergies from the combination.
• Success of integration plans and potential management distraction.
• Potential undisclosed liabilities not identified in due diligence.
• Accuracy of combined and pro forma financial information.
• Ability of Gildan to obtain financing under the Debt Commitment Letter or permanent replacement financing, and to refinance Hanesbrands existing debt.
• Macroeconomic, financial, or geopolitical changes affecting demand and operations.
• Competitive intensity and ability to compete effectively; reliance on a small number of significant customers with no minimum purchase commitments.
• Demand forecasting, production, and inventory management risks amid changing consumer preferences.
• Volatility in raw materials and energy prices and reliance on key suppliers.
• Operational disruptions from logistics, labor issues, instability, weather, natural disasters, epidemics/pandemics, and other unforeseen events.
• Compliance with trade, competition, tax, environmental, health and safety, product liability, employment, IP, data privacy, anti-corruption and other regulations.
• Trade remedies, tariffs, and changes to trade programs and agreements, including U.S. tariffs and any retaliatory measures.
• Elimination or non-realization of government subsidies and credits.
• Tax risks, including higher effective tax rates, audit outcomes, and changes in tax laws or treaties.
• Changes to consumer product safety and employment laws; ability to attract and retain key personnel.
• Reputational risk from alleged labor, human rights, or environmental violations by the company or contractors.
• IP protection challenges; IT systems failures; cybersecurity breaches; data security incidents; and risks from rapid AI developments.
• Financial risks from credit, liquidity, FX, interest rates, and commodities.
• Hanesbrands-specific risks: execution of strategic plans, supply chain restructuring, cost savings initiatives, rapidly changing retail environment, deleveraging progress, IT adequacy, potential impairment of intangibles/goodwill, FX volatility, international operations and tax structure complexity.
• Stockholder litigation and demand letters seeking injunctions, fees, and potential damages.

Future Outlook

Management reiterates the expected closing of the Gildan transaction subject to approvals, financing under the Debt Commitment Letter or permanent replacement, and successful integration and synergy realization; a post-closing strategic alternatives review is planned for Hanesbrands Australia.

Management Comments

• The board of directors continues to recommend that stockholders vote FOR approval of the transactions and related proposals at the special meeting.
• Hanesbrands and Gildan deny the disclosure allegations but voluntarily supplemented disclosures to moot claims and avoid potential disruption.

Industry Context

The apparel space has a history of consolidation at mid- to high-single-digit EV/EBITDA multiples. The selected precedent transactions cited—PVH/Tommy Hilfiger and PVH/Warnaco (8.1x–8.5x), Coach/Kate Spade (9.3x), Sycamore/Jones Group (8.3x), Ascena/ANN (7.7x), Boardriders/Billabong (7.4x), TowerBrook/J.Jill (6.0x)—frame the offered value and pro forma assumptions. The combined company multiples and synergy expectations fall within this historical range, consistent with broader branded basics and lifestyle apparel consolidation dynamics.

Comparison to Industry Standards

• Offer valuation vs. precedents: The selected transactions range (6.0x–9.3x EV/LTM EBITDA) aligns with the implied standalone exit multiples (6.3x–8.5x) and pro forma exit multiples (8.2x–12.6x), suggesting the consideration is broadly consistent with historical apparel M&A benchmarks.
• Comparable deals cited: PVH/Tommy Hilfiger (8.5x) and PVH/Warnaco (8.1x) anchor premium branded transactions; Coach/Kate Spade (9.3x) indicates higher-end lifestyle premium; Ascena/ANN (7.7x), Sycamore/Jones (8.3x), Boardriders/Billabong (7.4x), and TowerBrook/J.Jill (6.0x) represent mid-range outcomes.
• Pro forma multiples: The 8.5x–11.0x EV/NTM EBITDA framework used for the combined entity is within the historical spectrum for scaled apparel platforms, with the upper end reflecting anticipated synergy capture and stronger growth/FCF profile.

Legal Proceedings

• John Burke v. Hanesbrands Inc., et al. (filed November 4, 2025, NY Supreme Court): alleges negligent misrepresentations/concealment and negligence related to proxy/prospectus disclosures; seeks injunction, attorneys’ fees, and if closed, actual and punitive damages.
• John Carroll v. Hanesbrands Inc., et al. (filed November 5, 2025, NY Supreme Court): similar disclosure-based claims; seeks injunction, attorneys’ fees, and potential damages.
• Receipt of multiple demand letters alleging disclosure deficiencies; additional similar complaints or demands may be received and may not be separately disclosed.

Stakeholder Impact

• Shareholders face a defined cash-and-stock consideration with valuation ranges provided to assess deal value.
• Potential for transaction-related litigation to seek injunctive relief could affect timing if successful.
• Refinancing and new debt financing may increase leverage at closing, impacting creditors and bondholders.
• NOL utilization and synergy realization, if achieved, could enhance free cash flow for the combined entity.
• Employees and suppliers may experience integration-related changes depending on synergy and restructuring plans.

Next Steps

• Hold the virtual special meeting on November 25, 2025 to vote on the merger.
• Obtain all required shareholder and regulatory approvals to close.
• Secure financing under the Debt Commitment Letter and/or permanent replacement financing and refinance Hanesbrands existing debt.
• Conduct Gildan’s planned post-closing strategic alternatives review of Hanesbrands Australia.
• File any additional transaction-related documents with the SEC and, for Gildan, Canadian securities regulators as needed.

Key Dates

Recommendation

With the merger terms set and the board’s FOR recommendation, the key variable for investors is execution—securing approvals and financing, closing on schedule, and realizing synergies. Valuation ranges indicate upside potential versus some standalone scenarios but also highlight downside at the low end. Pending litigation, leverage, and integration risks argue for a neutral stance until the shareholder vote and financing milestones are cleared.

Keywords

Hanesbrands, Gildan Activewear, merger, proxy statement, prospectus, Form 8-K, DCF valuation, exchange ratio, EV/EBITDA, NOL tax benefits, special meeting, litigation, debt financing, synergies, apparel industry M&A